Comparing two treatments for benign prostatic hyperplasia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of Prostate Artery Embolization (PAE) compared to Transurethral Prostate Resection (TURP) in treating benign prostatic hyperplasia, which causes lower urinary tract symptoms. The research focuses on medical outcomes, complications, costs, and perceived quality of life associated with both treatments. Patients will be assessed based on specific criteria, including prostate volume and urinary flow rates, to determine their eligibility for either intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Benign prostatic hyperplasia where medical treatment has not helped or for other reasons has not been deemed applicable
* IPSS\>=12
* Prostate volume \[40-100\] ml measured via transrectal ultrasound
* Peak flow rate (Qmax) \<= 15 ml / s,
* Verified obstruction by urodynamic studies (cystometry)
* Surgery not contraindicated

Exclusion Criteria:

* known prostate or bladder cancer
* Severe atherosclerosis
* Kidney failure eGFR \< 30
* Urethral stricture
* Active cystitis or prostatitis
* Bladder stone.
* Neurogenic bladder disorder
* known allergy to iodinated contrast medium

Where it's running

• Region Vastmanland Hospital
  Västerås, Västmanland County, Sweden Recruiting
• Helsingborgs Hospital
  Helsingborg, Region Skånes, Sweden Not yet recruiting
• Mälarsjukhuset
  Eskilstuna, Region Sörmland, Sweden Not yet recruiting
• Lasarettet i Enköping
  Enköping, Region Uppsala, Sweden Not yet recruiting

Study contacts

• Principal investigator: Abbas Chabok — CKF Västerås Uppsala university
• Study coordinator: Emir Majbar, MD
• Email: emir.majbar@regionvastmanland.se
• Phone: +46-021176939

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing prostate artery embolization to surgery for enlarged prostate treatment

  This study is testing whether a new procedure called prostate artery embolization works as well as traditional surgery for men with an enlarged prostate and bothersome urinary symptoms.

  Recruiting Oslo University Hospital · Oslo · NCT04084938

• Evaluating alpha-blocker therapy for managing urinary symptoms after prostate surgery

  This study is testing if the medication Tamsulosin can help men feel better by reducing painful and bothersome urinary symptoms after prostate surgery.

  Recruiting Ankara Training and Research Hospital · Ankara · NCT06865430

• Adaptive radiotherapy for localized prostate cancer

  This study is testing a new type of radiation therapy for men with localized prostate cancer who have urinary problems to see if it can safely treat their cancer without causing too many side effects.

  Recruiting University of Zurich · Heidelberg, Baden-Wurttemberg and 2 other locations · NCT06834152

• Bipolar TURP versus MOSES‑assisted Holmium laser enucleation for enlarged prostate

  This trial will test whether MOSES‑assisted Holmium laser enucleation (MoLEP) or bipolar transurethral resection (Bi‑TURP) leads to shorter hospital stays and improved intraoperative outcomes for men with symptomatic benign prostatic hyperplasia and prostate volumes of 40–80 cc.

  Recruiting at 5 sites Fundacio Puigvert · Santiago de Compostela, A Coruña and 5 other locations · NCT06649357

• Comparing robotic and laser surgery for prostate enlargement treatment

  This study is testing whether robotic surgery or laser surgery is better for treating men with prostate enlargement who haven't found relief from other treatments.

  Recruiting University of Illinois Chicago · Chicago, Illinois · NCT06224218

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.